Inventor · disambiguated record
Lin An
Also filed as: AN LIN · An lin-kun
7 granted patents·2 pending applications·55 citations·filing 2010–2019
82Inventor score
Files withZEISS CARL MEDITEC INC6THE US SECRETARY DEPARTMENT OF HEALTH AND HUMAN SERVIC1UNIV OREGON HEALTH & SCIENCE1WANG RUIKANG1
Top patents by PatentIndex Score
9 records- 0195US9759544B2Methods of reducing motion artifacts for optical coherence tomography angiographyZEISS CARL MEDITEC INC·Filed 2015·Granted Sep 12, 2017·20 cites·18 claims
- 0294US9700206B2Acquistion and analysis techniques for improved outcomes in optical coherence tomography angiographyZEISS CARL MEDITEC INC·Filed 2016·Granted Jul 11, 2017·23 cites·14 claims
- 0378US10368734B2Methods and systems for combined morphological and angiographic analyses of retinal featuresZEISS CARL MEDITEC INC·Filed 2016·Granted Aug 6, 2019·5 cites·4 claims
- 0469US8750586B2Method and apparatus for quantitative imaging of blood perfusion in living tissueWANG RUIKANG·Filed 2010·Granted Jun 10, 2014·6 cites·23 claims
- 0564US10264963B2Methods for high sensitivity flow visualizationZEISS CARL MEDITEC INC·Filed 2016·Granted Apr 23, 2019·1 cites·17 claims
- 0661US10743763B2Acquisition and analysis techniques for improved outcomes in optical coherence tomography angiographyZEISS CARL MEDITEC INC·Filed 2019·Granted Aug 18, 2020·0 cites·11 claims
- 0754US10238284B2Acquisition and analysis techniques for improved outcomes in optical coherence tomography angiographyZEISS CARL MEDITEC INC·Filed 2017·Granted Mar 26, 2019·0 cites·10 claims
- 0850US2014288419A1Method and apparatus for quantitative imaging of blood perfusion in living tissueUNIV OREGON HEALTH & SCIENCE·Filed 2014·Application pending·0 cites
- 0946US2023219895A1Oxynitidine derivatives useful as inhibitors of topoisomerase ib (top1) and tyrosyl-dna phosphodiesterase 1 (tdp1)THE US SECRETARY DEPARTMENT OF HEALTH AND HUMAN SERVIC·Filed 2019·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Lin An files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →